NCT06550414View on ClinicalTrials.gov

Dexmedetomidine As An Adjuvant To Bupivacaine 0.1% in Labor Analgesia

NACompletedINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

May 1, 2023

Conditions
Labor AnalgesiaLabor Pain
Interventions
DRUG

Dexmedetomidine

Active comparator: dexmedetomidine group

DRUG

Bupivacain

Placebo comparator: bupivacaine group

Trial Locations (1)

042

Hameed Lateef Hospital, Lahore

All Listed Sponsors
lead

Services Institute of Medical Sciences, Pakistan

OTHER_GOV